Joette Nesladek Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 411 E. 2nd Street, Kennebec, SD 57544 Phone: 605-869-8813 |
News Archive
Indiana University cancer researchers found that a particular microRNA may be a potent therapeutic agent against pancreatic cancer. The research was published June 22 in the journal Scientific Reports.
Laboratory and Battelle Fellow Dick Smith of the Department of Energy's Pacific Northwest National Laboratory has been recognized for his many accomplishments in pioneering the development of proteomics tools. Scientists use these instruments to study the array of proteins and related molecules that make up much of human blood and tissues.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
Workplace violence perpetrated by military personnel is a major concern of the U.S. Department of Defense. Although programs have been implemented to teach violence prevention strategies to all military personnel, such programs are much less intensive than others developed in settings for people judged to be at high risk of violent behavior.
› Verified 1 days ago